AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)
$30.42 1.8 (6.2893%)
Analysed AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) News Sources
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
12-05-2026
yahoo.com
Sector Update: Healthcare Stocks Gain in Afternoon Trading
12-05-2026
yahoo.com
Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease
13-05-2026
yahoo.com
Agios sNDA And EHA Plenary Put Mitapivat At Center Of Valuation
13-05-2026
yahoo.com
How Agios’ Mitapivat sNDA And New SCD Trial Design At Agios Pharmaceuticals (AGIO) Has Changed Its Investment Story
15-05-2026
yahoo.com
Assessing Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Volatility
15-05-2026
yahoo.com
Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances
19-05-2026
marketbeat.com
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
22-05-2026
yahoo.com
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
22-05-2026
yahoo.com
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe
25-05-2026
yahoo.com
What is the current price of AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)?
The current price of AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) is $30.42.
AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) since the previous trading day is $1.8.
AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) since the previous trading day is 6.2893%.
What is the most recent average sentiment score for AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)?
The most recent average sentiment score for AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)?
The most recent sentiment for AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) is .
SEC-8K** Filing Available For AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.